Imaging research from the University Medical Center Utrecht, the Netherlands, suggests that measuring with MRI the intracranial pressure of infants with progressive hydrocephalus helps physicians to determine the right time for surgical intervention.
Imaging research from the University Medical Center Utrecht, the Netherlands, suggests that measuring with MRI the intracranial pressure of infants with progressive hydrocephalus helps physicians to determine the right time for surgical intervention.
According to a study published in the Journal of Neurosurgery: Pediatrics (2008;2[3]:163-170), the clinical signs of raised intracranial pressure associated with hydrocephalus can be unreliable and even misleading, mak-ing it difficult to tell if a shunt system is needed to divert excess cerebro-spinal fluid. Adding to the uncertainty, after sutures close in infants, actual intracranial pressure does not always correlate with ventricular size or clinical signs or symptoms.
Dr. Paul H. Leliefeld and colleagues prospectively assessed 15 children, from newborn to seven months old, with MR angiography before and after CSF diversion procedures. After CSF diversion (a shunt in 12 patients, and a third ventriculostomy in three), cerebral blood flow and intracranial pressure improved to values in the normal range. The researchers found the quantitative flow measurement, obtained with phase-contrast MRA though the internal carotid arteries and the basilar artery, accurately reflected cerebral blood flow.
The study may have been the first ever to associate a significant decrease in cerebral blood flow with progressive hydrocephalus, Leliefeld said. The decline may be explained by disturbed cerebral auto-regulation, a distortion of the periven-tricular vessels caused by ventricular dilation, or possibly an increase in blood flow resistance from the compression of arterioles and veins.
Hydrocephalus is a common pediatric disorder affecting one in 1000 live births characterized by abnormal dilation of the ventricles of the brain. Clinical signs of the disorder in infants include a larger-than-normal head circumference, bulging of the fontanel, engorgement of scalp veins, the downward gaze known as "sunset eyes," and decreased consciousness. Pressure from an oversupply of CSF can cause irreversible brain damage, making timely intervention critical.
Leliefeld prefers MRA to ultra-sound because it measures blood supply to the entire brain while ultra-sound measurement using transcranial Doppler is limited to the middle cerebral artery. MRA also detects early ischemia or restricted flow to the brain.
"When MRA is used for the diagnosis of hydrocephalus in infants, it's not harmful to make it last 10 minutes longer to perform the quantitative flow measurements," he said.
Not everyone is convinced. MRA and its accompanying high costs can be avoided with a better clinical analysis of suspected hydrocephalus, said Dr. Erin Simon Schwartz, a pediatric neuroradiologist at Children’s Hospital of Philadelphia. But she still considers MR to be cost-effective.
-By Marjorie Preston
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.